Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global bio implants market was valued at USD 185.21 billion in 2023. It is expected to grow at a CAGR of 8.2% during the forecast period of 2024-2032 and attain a market value of USD 376.45 billion by 2032. The market growth is driven by the rising prevalence of chronic diseases such as diabetes and cardiovascular diseases. Patents are focused on advanced technologies such as autografts, allografts, and xenografts among bio-implants.
The Global Bio Implants Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for Bio Implants include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with Bio Implants. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within Bio Implants technologies.
Patent Valuation Analysis
An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for bio implant technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with Bio Implants.
Analysis of Patent Applications
A comprehensive summary of several patent applications which were filed across different jurisdictions for bio implants and their relative value is covered. The analysis will cover the capital in terms of innovation and innovation type.
Analysis of Granted Patents
Detailed analysis of the granted patents across different jurisdictions for bio implants and their relative value in the IP are covered in the final report.
Bio implants are intended to be placed within or on top of the body to replace or sustain injured organs and tissues. Because of their biocompatible construction, they complement the body's natural processes and aid in healing. Dental implants, cardiovascular stents, and joint replacements are common examples.
The components of bio implants include autografts, allografts and xenografts. Tissues transferred from one area of a patient's body to another, known as autografts, are used in biopsies to replace diseased or damaged tissue with naturally occurring tissue. Since the tissue is from the same person, they are very biocompatible and lower the chance of rejection. Autografts facilitate improved integration and healing and are frequently utilized in procedures like skin grafting and bone repairs.
Technological Advancements is Expected to Boost the Patent Industry Growth
Continuous advancements in medical technology and materials science are improving the efficacy and security of bio implants. New biomaterials, enhanced imaging methods, and advanced manufacturing procedures are examples of advancements. For instance, HugoTM, a robotically assisted surgery platform by Medtronic is a sophisticated system that enhances the accuracy and results of minimally invasive surgeries involving implants by leveraging state-of-the-art robotics and imaging technologies. The platform promotes improved bio implant performance and integration by incorporating the most recent technological developments.
Patents covering these technologies are crucial for companies and thus impact the bio implants patent landscape. There has been an increase in patent activity which is focused at enhancing the performance of bio implants. In 2023, around 4,573 patents were granted.
Rising Chronic Diseases is Expected to Propel Bio Implants Patent Industry
The need for bio implants, which are used in devices like insulin pumps, pacemakers, and stents, is driven by the rising incidence of chronic illnesses like diabetes and cardiovascular diseases. The market is growing because these conditions require long-term management solutions.
The report will cover the following sections in detail:
Analysis by Origin
Analysis by Product
Analysis by Material
The breakup based on origin includes autografts, allografts, and xenografts. Tissues from donors of the same species but not the same person are used as allografts in biopsies. They are frequently used in procedures like organ transplants and bone grafting to replace missing or damaged tissue. Even though allografts are processed to reduce immune rejection, immunosuppressive medications may still be necessary.
The United States is one of the leading jurisdictions for bio implant patents, having around 162,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.
Among the players with bio implant patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the Bio Implants field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
The company is based in Dublin, Ireland, and was established in 1949. It is a leader in medical technology and bio implants worldwide. The company sells a variety of bioimplant products, such as cutting-edge tools for orthopedic, cardiovascular, and spinal applications. Modern implantable technologies and solutions are the focus of Medtronic's innovations, which are meant to enhance patient outcomes.
Founded in 1981, with its main office located in Hudson, New Hampshire, the company specializes in bio implant...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Genentech Inc., Amgen Inc., Boston Scient Scimed Inc., Bard Inc. C R, Bio Dg Inc., Samsung Electronics Co Ltd, Micron Technology Inc., Massachusetts Inst Technology, Millennium Pharm Inc., and Zymogenetics Inc., among others.
The bio implants patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
Scope of the Report | Details |
Analysis by Origin |
|
Analysis by Product |
|
Analysis by Material |
|
Key Players Mentioned |
|
Geographies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share